Cargando…
Novel Mutations Mapping to the Fourth Sodium Channel Domain of Nav1.7 Result in Variable Clinical Manifestations of Primary Erythromelalgia
We identified and clinically investigated two patients with primary erythromelalgia mutations (PEM), which are the first reported to map to the fourth domain of Nav1.7 (DIV). The identified mutations (A1746G and W1538R) were cloned and transfected to cell cultures followed by electrophysiological an...
Autores principales: | Cregg, Roman, Laguda, Bisola, Werdehausen, Robert, Cox, James J., Linley, John E., Ramirez, Juan D., Bodi, Istvan, Markiewicz, Michael, Howell, Kevin J., Chen, Ya-Chun, Agnew, Karen, Houlden, Henry, Lunn, Michael P., Bennett, David L. H., Wood, John N., Kinali, Maria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Humana Press Inc
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650253/ https://www.ncbi.nlm.nih.gov/pubmed/23292638 http://dx.doi.org/10.1007/s12017-012-8216-8 |
Ejemplares similares
-
Mexiletine as a treatment for primary erythromelalgia: normalization of biophysical properties of mutant L858F Na(V)1.7 sodium channels
por: Cregg, R, et al.
Publicado: (2014) -
Erythromelalgia: a cutaneous manifestation of neuropathy?
por: Leroux, María Bibiana
Publicado: (2018) -
Temperature dependence of erythromelalgia mutation L858F in sodium channel Nav1.7
por: Han, Chongyang, et al.
Publicado: (2007) -
Pathological nociceptors in two patients with erythromelalgia‐like symptoms and rare genetic Nav 1.9 variants
por: Kleggetveit, Inge P., et al.
Publicado: (2016) -
Neurological perspectives on voltage-gated sodium channels
por: Eijkelkamp, Niels, et al.
Publicado: (2012)